DOYLE WILLIAM F

CIK 00011944596 companiesWINSTON SALEM, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001194459

Recent Transactions

50 trades

Award
PROKIDNEY CORP.$PROK
Director stock option (right to buy)
2025-05-29+125,862→ 125,862 total
Award
Elanco Animal Health Inc$ELAN
Common Stock
2024-11-29+18,169→ 94,499 total
Award
PROKIDNEY CORP.$PROK
Director stock option (right to buy)
2024-05-30+62,558→ 62,558 total
Purchase
Elanco Animal Health Inc$ELAN
Common Stock
2024-05-21$16.98/sh+15,000→ 76,330 total
Purchase
Elanco Animal Health Inc$ELAN
Common Stock
2024-03-08$16.30/sh+15,000→ 61,330 total
Award
Elanco Animal Health Inc$ELAN
Common Stock
2023-11-30+20,374→ 46,330 total
Award
PROKIDNEY CORP.$PROK
Director Stock Option (right to buy)
2023-06-29+48,128→ 48,128 total
Award
Elanco Animal Health Inc$ELAN
Common Stock
2022-11-30+18,649→ 25,956 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2022-08-02$69.66/sh−837→ 551,176 total
Award
PROKIDNEY CORP.$PROK
Class B Ordinary Shares
2022-07-11+1,514,326→ 1,514,326 total
Award
PROKIDNEY CORP.$PROK
Common Units in ProKidney LP
2022-07-11+1,514,326→ 1,514,326 total
Award
Minerva Neurosciences, Inc.$NERV
Stock Option (right to buy)
2022-06-10+2,500→ 2,500 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2022-03-08$70.10/sh−2,385→ 552,013 total
Award
NovoCure Ltd$NVCR
Options to Buy Ordinary Shares
2022-03-03$80.59/sh+14,581→ 14,581 total
Award
Elanco Animal Health Inc$ELAN
Common Stock
2021-11-30+7,307→ 7,307 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-08-02$149.38/sh−995→ 554,398 total
Award
Minerva Neurosciences, Inc.$NERV
Stock Option (right to buy)
2021-06-11+40,000→ 40,000 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$204.28/sh−1,972→ 568,698 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$207.80/sh−4,500→ 561,314 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$191.26/sh−1,400→ 648,993 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$216.69/sh−600→ 555,393 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$211.28/sh−600→ 557,993 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$206.35/sh−1,284→ 565,814 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$209.34/sh−2,200→ 559,114 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$202.16/sh−4,388→ 573,225 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$203.25/sh−2,555→ 570,670 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$201.55/sh−4,125→ 577,613 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$198.98/sh−10,563→ 586,076 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$205.43/sh−1,600→ 567,098 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$194.94/sh−1,600→ 643,403 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$214.66/sh−500→ 555,993 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$197.00/sh−24,338→ 610,251 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$213.35/sh−1,500→ 556,493 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$196.07/sh−8,814→ 634,589 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$210.18/sh−521→ 558,593 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$192.52/sh−1,900→ 647,093 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$199.71/sh−4,338→ 581,738 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$193.57/sh−2,090→ 645,003 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-13$197.83/sh−13,612→ 596,639 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2021-04-01$134.12/sh−7,928→ 650,393 total
Exercise/Conversion
NovoCure Ltd$NVCR
Restricted Stock Units
2021-03-31−9,259→ 0 total
Exercise/Conversion
NovoCure Ltd$NVCR
Ordinary Shares
2021-03-31$125.25/sh+9,259→ 658,321 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2020-07-31$76.39/sh−896→ 649,062 total
Award
Minerva Neurosciences, Inc.$NERV
Stock Option (right to buy)
2020-06-11+40,000→ 40,000 total
Award
OptiNose, Inc.
Stock Option (Right to Buy)
2020-06-10$5.65/sh+14,439→ 14,439 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2020-05-11$63.73/sh−31,332→ 649,958 total
Sale
NovoCure Ltd$NVCR
Ordinary Shares
2020-05-08$63.50/sh−31,903→ 681,290 total
Exercise/Conversion
NovoCure Ltd$NVCR
Ordinary Shares
2020-05-08$63.84/sh+58,767→ 713,193 total
Exercise/Conversion
NovoCure Ltd$NVCR
Restricted Stock Units
2020-05-08−58,767→ 0 total
Exercise/Conversion
NovoCure Ltd$NVCR
Ordinary Shares
2020-05-07$64.77/sh+58,768→ 685,419 total

DOYLE WILLIAM F

Recent Transactions

Companies

Recent Filings

Address